Waverley Pharma Inc (WAVE) - Total Liabilities

Latest as of March 2026: CA$3.92 Million CAD ≈ $2.84 Million USD

Based on the latest financial reports, Waverley Pharma Inc (WAVE) has total liabilities worth CA$3.92 Million CAD (≈ $2.84 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see Waverley Pharma Inc (WAVE) total assets.

Waverley Pharma Inc - Total Liabilities Trend (2015–2025)

This chart illustrates how Waverley Pharma Inc's total liabilities have evolved over time, based on quarterly financial data. See Waverley Pharma Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Waverley Pharma Inc Competitors by Total Liabilities

The table below lists competitors of Waverley Pharma Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Hitech & Development Wireless Sweden Holding AB (publ) ST:HDW-B	Sweden	Skr8.22 Million
Nulegacy Gold Corporation V:NUG	Canada	CA$565.65K
ArcelorMittal SA LSE:0RP9	UK	€40.98 Billion
African Dawn Capital Ltd JSE:ADW	South Africa	ZAC73.56 Million
Discovery Harbour Resources Corp V:DHR	Canada	CA$164.78K
PT Century Textile Industry Tbk JK:CNTX	Indonesia	Rp911.16 Billion
CHINA HEALTH GRP HD-10 F:VNL1	Germany	€31.60 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Waverley Pharma Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Waverley Pharma Inc (WAVE) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	3.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Waverley Pharma Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Waverley Pharma Inc (2015–2025)

The table below shows the annual total liabilities of Waverley Pharma Inc from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	CA$3.82 Million ≈ $2.76 Million	-6.43%
2024-12-31	CA$4.08 Million ≈ $2.95 Million	+95.18%
2023-12-31	CA$2.09 Million ≈ $1.51 Million	+30.87%
2022-12-31	CA$1.60 Million ≈ $1.15 Million	-15.76%
2021-12-31	CA$1.89 Million ≈ $1.37 Million	+30.77%
2020-12-31	CA$1.45 Million ≈ $1.05 Million	-6.42%
2019-12-31	CA$1.55 Million ≈ $1.12 Million	+22.48%
2018-12-31	CA$1.26 Million ≈ $914.54K	-21.04%
2017-12-31	CA$1.60 Million ≈ $1.16 Million	+13556.93%
2016-12-31	CA$11.72K ≈ $8.48K	+10.13%
2015-12-31	CA$10.65K ≈ $7.70K	--

About Waverley Pharma Inc

V:WAVE Canada Biotechnology

Market Cap

$585.94K

CA$810.00K CAD

Market Cap Rank

#30933 Global

#1636 in Canada

Share Price

CA$0.02

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.03

All Time High

CA$0.60